featured
Pembrolizumab Plus Chemoradiation in Unresectable, Locally Advanced, Stage III NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Pembrolizumab Plus Concurrent Chemoradiation Therapy in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer: The Phase 2 KEYNOTE-799 Nonrandomized Trial
JAMA Oncol 2021 Jun 04;[EPub Ahead of Print], SK Jabbour, KH Lee, N Frost, V Breder, DM Kowalski, T Pollock, E Levchenko, N Reguart, A Martinez-Marti, B Houghton, JB Paoli, S Safina, K Park, T Komiya, A Sanford, V Boolell, H Liu, A Samkari, SM Keller, M ReckFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.